November 2024 – Page 4 – PROSTATE WARRIORS – The latest news about prostate cancer

Breakthrough discovery (in vitro): selective MMP7 inhibitor for cancer treatment

November 9, 2024/0 Comments/in Not PCa related, Preclinical Research/by Max

Onchilles Pharma’s (potentially) Groundbreaking Pan-Cancer Therapeutics: Targeting the ELANE Pathway

November 8, 2024/0 Comments/in Immunotherapy, Preclinical Research/by Max

Early PSA Response as a Predictor and Mediator of Treatment Efficacy in Metastatic Hormone Sensitive Prostate Cancer

November 7, 2024/0 Comments/in Post-hoc, Retrospective studies/by Max

Phase 3 trial: 177Lu-DOTA-rosopatamab (TLX591) for patients with PSMA expressing metastatic castration-resistant prostate cancer

November 7, 2024/0 Comments/in Clinical Trial, Metastatic, Phase 3/by Max

A Phase 1 trial to keep an eye on: Thorium-227 (BAY2315497) in metastatic Castration Resistant Prostate Cancer

November 6, 2024/0 Comments/in Clinical Trial, Metastatic, Phase 1/by Max

Hope for Aggressive Prostate Cancer: A Case Study with T-DXd

November 5, 2024/0 Comments/in Case studies/by Max

PSA Kinetics Predict Survival Outcomes in High-Volume Metastatic Prostate Cancer

November 5, 2024/0 Comments/in Retrospective studies/by Max

Breaking Barriers: FDA Approval of Tecelra Marks a New Era for TCR Therapy in Solid Tumors

November 4, 2024/0 Comments/in Not PCa related/by Max

Not related to prostate cancer but really interesting: allogenic CAR-T is getting good results!

November 2, 2024/0 Comments/in Not PCa related/by Max

Benfo-Oxythiamine Shows Promise as a Radiosensitizer in mCRPC

November 1, 2024/0 Comments/in Clinical Trial, Metastatic, Phase 1/by Max